Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients

Authors

  • K Nahar Department of Pathology & Microbiology, Islamia Eye Hospital & Mirza Ahmed Ispahani Institute of Ophthalmology
  • M Jahan Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • A Nessa Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • S Tabassum Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/bmrcb.v37i3.9119

Keywords:

Antibody responses, hepatitis B vaccination, maintenance haemodialysis patients

Abstract

In haemodialysis patients, hepatitis B virus infection has higher mortality and is more likely to result in the carrier state. Although Hepatitis B vaccine is effective in producing protection against HBV infection, the antibody response may be variable. In this study, seroprotection rate of hepatitis B vaccine in maintenance haemodialysis patients was studied after primary vaccination and after completion of the full vaccine regime. 50 unvaccinated patients on maintenance haemodialysis were included in this study. Patients negative for HBsAg, Anti-HBc (total) and Anti-HCV were vaccinated with 40μg of Engerix B following a schedule of 0, 1, and 2 months. The antibody titer was tested at 3rd month and if the titer was <10 or between 10-100 mIU/ml, they were given another 4th dose of vaccine at 6th month, and their antibody titer was tested again at 7th month. In maintenance haemodialysis patients, the response rate to HBV vaccine was 44% after the primary vaccination and 80% after completion of the full vaccine regime.

DOI: http://dx.doi.org/10.3329/bmrcb.v37i3.9119

BMRCB 2011; 37(3): 88-91

Downloads

Download data is not yet available.
Abstract
148
PDF
301

Downloads

How to Cite

Nahar, K., Jahan, M., Nessa, A., & Tabassum, S. (2011). Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients. Bangladesh Medical Research Council Bulletin, 37(3), 88–91. https://doi.org/10.3329/bmrcb.v37i3.9119

Issue

Vol. 37 No. 3 (2011)

Section

Research Papers

License

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).